Analysis of Nasal Polyps Suggests Mechanisms of Inflammation
By LabMedica International staff writers Posted on 04 Sep 2018 |
Image: Diagram of the Seq-Well low-cost platform for single-cell RNA sequencing (Photo courtesy of Shalek Lab).
Allergic inflammation can develop from persistent activation of type 2 immunity in the upper airway, resulting in chronic rhinosinusitis, which ranges in severity from rhinitis to severe nasal polyps.
Basal cell hyperplasia is a hallmark of severe disease, but it is not known how these progenitor cells contribute to clinical presentation and barrier tissue dysfunction in humans. In an effort to elucidate molecular mechanisms of chronic inflammatory diseases, scientists have profiled the transcriptomes of human nasal polyps and nasal scrapings by single-cell RNA sequencing.
Scientists at Brigham and Women's Hospital (Boston, MA, USA) and their colleagues performed single-cell RNA sequencing on more than 18,000 cells from 12 surgically removed nasal polyps spanning the disease spectrum. They used Seq-Well for massively parallel single-cell RNA sequencing, report transcriptomes for human respiratory epithelial, immune and stromal cell types and subsets from a type 2 inflammatory disease, and map key mediators. Seq-Well is a portable, low-cost platform for single-cell RNA sequencing designed to be compatible with low-input, clinical biopsies.
The investigators found that the diversity of epithelial cell types was reduced in the nasal polyps, which contained few glandular and ciliated cells and were enriched in basal cells. The latter appeared to be stuck in their ability to differentiate into other cell types. This reduction in cellular diversity might be explained by differences in gene expression the scientists found between polyp and non-polyp basal progenitor cells. In addition, they revealed that a transcriptional program that is activated by cytokines interleukin-4 (IL-4 ) and IL-13 is strongly induced in basal progenitor cells from polyps, suggesting a possible treatment with an antibody that blocks the shared IL-4/IL-13 receptor subunit.
The authors concluded that that reduced epithelial diversity stemming from functional shifts in basal cells is a key characteristic of type 2 immune-mediated barrier tissue dysfunction. Their results demonstrate that epithelial stem cells may contribute to the persistence of human disease by serving as repositories for allergic memories. The study was published on August 22, 2018, in the journal Nature.
Related Links:
Brigham and Women's Hospital
Basal cell hyperplasia is a hallmark of severe disease, but it is not known how these progenitor cells contribute to clinical presentation and barrier tissue dysfunction in humans. In an effort to elucidate molecular mechanisms of chronic inflammatory diseases, scientists have profiled the transcriptomes of human nasal polyps and nasal scrapings by single-cell RNA sequencing.
Scientists at Brigham and Women's Hospital (Boston, MA, USA) and their colleagues performed single-cell RNA sequencing on more than 18,000 cells from 12 surgically removed nasal polyps spanning the disease spectrum. They used Seq-Well for massively parallel single-cell RNA sequencing, report transcriptomes for human respiratory epithelial, immune and stromal cell types and subsets from a type 2 inflammatory disease, and map key mediators. Seq-Well is a portable, low-cost platform for single-cell RNA sequencing designed to be compatible with low-input, clinical biopsies.
The investigators found that the diversity of epithelial cell types was reduced in the nasal polyps, which contained few glandular and ciliated cells and were enriched in basal cells. The latter appeared to be stuck in their ability to differentiate into other cell types. This reduction in cellular diversity might be explained by differences in gene expression the scientists found between polyp and non-polyp basal progenitor cells. In addition, they revealed that a transcriptional program that is activated by cytokines interleukin-4 (IL-4 ) and IL-13 is strongly induced in basal progenitor cells from polyps, suggesting a possible treatment with an antibody that blocks the shared IL-4/IL-13 receptor subunit.
The authors concluded that that reduced epithelial diversity stemming from functional shifts in basal cells is a key characteristic of type 2 immune-mediated barrier tissue dysfunction. Their results demonstrate that epithelial stem cells may contribute to the persistence of human disease by serving as repositories for allergic memories. The study was published on August 22, 2018, in the journal Nature.
Related Links:
Brigham and Women's Hospital
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans